Changing the FDA Approval Process

Talk by Susan Desmond-Hellmann, Chancellor of UCSF


Uploaded by Essinova on March 21, 2011

This video is an excerpt of the speaker's talk for the Entrepreneurial Thought Leaders Lecture Series at Stanford University.

Susan Desmond-Hellmann, chancellor of UCSF, has a big idea to change the drug approval process at the Food and Drug Administration (FDA). The current process is binary, allowing for only a yes or no from the reviewer for drug approval. Desmond-Hellmann suggests that a variable approval process, that can change status as greater evidence comes in over time, will encourage more innovative products and even investment funding, based on product confidence.

Tags: Susan Desmond-Hellmann, UCSF, FDA



There are 0 comments. You must be logged in to comment.

Opinions & Expertise

 photo Essinova-Brain-and-Mind-banner_iStock_000004422514Medium.jpg

 photo Essinova_Art-and-Science-banner_PIA09962.jpg